What consumers should know about the FTC's upcoming lawsuit against CVS over how it negotiates drug prices

By The Boston Globe
| July 18, 2024

For more than two years, the FTC has been investigating whether PBMs steer patients away from more affordable medicines, particularly with insulin.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...